These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Apolipoprotein E in the genetics and epidemiology of Alzheimer's disease. Hardy J Am J Med Genet; 1995 Oct; 60(5):456-60. PubMed ID: 8546162 [TBL] [Abstract][Full Text] [Related]
46. Alzheimer's disease or Alzheimer's diseases? Clues from molecular epidemiology. Hyman BT Ann Neurol; 1996 Aug; 40(2):135-6. PubMed ID: 8773592 [No Abstract] [Full Text] [Related]
47. Genetics of Alzheimer's disease: an insight into presenilins and apolipoprotein E instigated neurodegeneration. Obulesu M; Somashekhar R; Venu R Int J Neurosci; 2011 May; 121(5):229-36. PubMed ID: 21545304 [TBL] [Abstract][Full Text] [Related]
48. Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain. Lleó A; Blesa R; Queralt R; Ezquerra M; Molinuevo JL; Peña-Casanova J; Rojo A; Oliva R Arch Neurol; 2002 Nov; 59(11):1759-63. PubMed ID: 12433263 [TBL] [Abstract][Full Text] [Related]
50. Gene identification in Alzheimer's disease. Saunders AM Pharmacogenomics; 2001 Aug; 2(3):239-49. PubMed ID: 11535112 [TBL] [Abstract][Full Text] [Related]
51. Presenile because of presenilin: the presenilin genes and early onset Alzheimer's disease. Haass C Curr Opin Neurol; 1996 Aug; 9(4):254-9. PubMed ID: 8858181 [TBL] [Abstract][Full Text] [Related]
52. The genetics of Alzheimer disease: back to the future. Bertram L; Lill CM; Tanzi RE Neuron; 2010 Oct; 68(2):270-81. PubMed ID: 20955934 [TBL] [Abstract][Full Text] [Related]
53. Novel intronic polymorphisms in the presenilin-2 gene and a case-control association study of Alzheimer's disease. Honda M; Kaname T; Igata-Yi R; Igata T; Hitoshi Y; Ogomori K; Miyakawa T; Yamamura KI Psychiatry Clin Neurosci; 1999 Oct; 53(5):579-85. PubMed ID: 10595683 [TBL] [Abstract][Full Text] [Related]
54. No association between the intronic presenilin-1 polymorphism and Alzheimer's disease in clinic and population-based samples. Cai X; Stanton J; Fallin D; Hoyne J; Duara R; Gold M; Sevush S; Scibelli P; Crawford F; Mullan M Am J Med Genet; 1997 Apr; 74(2):202-3. PubMed ID: 9129725 [TBL] [Abstract][Full Text] [Related]
55. ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families. Houlden H; Crook R; Backhovens H; Prihar G; Baker M; Hutton M; Rossor M; Martin JJ; Van Broeckhoven C; Hardy J Am J Med Genet; 1998 Feb; 81(1):117-21. PubMed ID: 9514597 [TBL] [Abstract][Full Text] [Related]
56. Translational research in genomics of Alzheimer's disease: a review of current practice and future perspectives. Mihaescu R; Detmar SB; Cornel MC; van der Flier WM; Heutink P; Hol EM; Rikkert MG; van Duijn CM; Janssens AC J Alzheimers Dis; 2010; 20(4):967-80. PubMed ID: 20182048 [TBL] [Abstract][Full Text] [Related]
57. The current status of Alzheimer's disease genetics: what do we tell the patients? Bertram L; Tanzi RE Pharmacol Res; 2004 Oct; 50(4):385-96. PubMed ID: 15304236 [TBL] [Abstract][Full Text] [Related]